Pub. Date : 2022 May
PMID : 35579577
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The US Food and Drug Administration has approved 3 next-generation AR inhibitors for nonmetastatic CRPC: apalutamide, enzalutamide, and darolutamide. | enzalutamide | androgen receptor | Homo sapiens |